{"id":601171,"date":"2026-06-25T14:03:36","date_gmt":"2026-06-25T14:03:36","guid":{"rendered":"https:\/\/www.olympiajournal.com\/news\/story\/601171\/nad-therapy-emerges-as-a-defining-category-in-2026-longevity-telehealth-telehealthreviewedcom-reports.html"},"modified":"2026-06-25T14:03:36","modified_gmt":"2026-06-25T14:03:36","slug":"nad-therapy-emerges-as-a-defining-category-in-2026-longevity-telehealth-telehealthreviewedcom-reports","status":"publish","type":"post","link":"https:\/\/www.pennsylvania-magazine.com\/news\/story\/601171\/nad-therapy-emerges-as-a-defining-category-in-2026-longevity-telehealth-telehealthreviewedcom-reports.html","title":{"rendered":"NAD+ Therapy Emerges as a Defining Category in 2026 Longevity Telehealth, TelehealthReviewed.com Reports"},"content":{"rendered":"
\n
\"NAD+<\/a><\/div>\n
\n
“NAD+ therapy has moved from niche biohacking to mainstream longevity conversation.” \u2014 TelehealthReviewed.com Editorial Team<\/div>\n<\/div>\n<\/div>\n
A new industry trend report from TelehealthReviewed.com examines how NAD+ therapy has emerged as a defining category in 2026 longevity telehealth, exploring how platforms position cellular health programs within the broader optimization landscape \u2014 with Bodybuilding Health Plus included among the platforms covered in the publication’s editorial library.<\/div>\n

TelehealthReviewed.com today published a new industry trend report examining the rise of NAD+ therapy as a defining category in 2026 longevity telehealth. The report analyzes how platforms are positioning cellular health programs, what consumer demand looks like, and how editorial coverage has evolved to keep pace with the category’s growth.<\/p>\n

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy production and is increasingly studied for its potential role in supporting vitality, cognitive clarity, and metabolic function. The publication’s report emphasizes that scientific research on NAD+ supplementation is ongoing and that consumers should evaluate any longevity program in the context of their individual health profile and provider guidance.<\/p>\n

Among the platforms referenced in the trend report is Bodybuilding Health Plus<\/a>, which TelehealthReviewed.com’s editorial team has examined as part of its expanding coverage library. According to publicly available information, the platform offers NAD+ therapy as part of its longevity and optimization program category, alongside sermorelin therapy and other personalized clinical options. The platform operates under the medical advisory leadership of Dr. Mark Rosenberg, M.D., a board-certified physician specializing in anti-aging medicine.<\/p>\n

The trend report notes that longevity telehealth is one of the fastest-growing segments of the broader telehealth industry and emphasizes that consumer education is critical as new programs enter the market. TelehealthReviewed.com encourages readers to consult with licensed providers about whether any longevity therapy is appropriate for their individual health needs.<\/p>\n

The complete trend report is available now on TelehealthReviewed.com<\/a>.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Bodybuilding Health Plus reviews<\/a>
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 713-392-6222
Address:<\/strong>526 Kingwood Dr. #165
City:<\/strong> Kingwood
State:<\/strong> TX
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.telehealthreviewed.com\/<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“NAD+ therapy has moved from niche biohacking to mainstream longevity conversation.” \u2014 TelehealthReviewed.com Editorial Team A new industry trend report from TelehealthReviewed.com examines how NAD+ therapy has emerged as a<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/posts\/601171"}],"collection":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/comments?post=601171"}],"version-history":[{"count":0,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/posts\/601171\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/media?parent=601171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/categories?post=601171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pennsylvania-magazine.com\/news\/wp-json\/wp\/v2\/tags?post=601171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}